COVID Appears to Raise Risk for Alzheimer’s Disease
FRIDAY, Sept. 16, 2022 (HealthDay News) — COVID-19 infection may significantly boost an older person’s risk of developing Alzheimer’s disease, a new, large-scale study suggests.People 65 and older who contracted COVID were nearly 70% more likely over…
Learn MoreIn Boxers and MMA Fighters, Brain May Make Some Recovery After Retirement
THURSDAY, Sept. 15, 2022 (HealthDay News) — Professional fighters take a lot of knocks to the head, but a new study suggests they may find themselves thinking more clearly again after they retire.Many studies have pointed to the perils of repeated bl…
Learn MoreConcussion Aftermath Could Drag Down Teens’ Grades
WEDNESDAY, Sept. 14, 2022 (HealthDay News) — Efforts to prevent concussions from happening at school or school-related sports activities may help keep teens from lagging behind on their academics.In a new study, researchers at the University of Washi…
Learn MoreEn casos raros, la viruela del simio puede provocar una peligrosa inflamación en el cerebro
LUNES, 12 de septiembre de 2022 (HealthDay News) — Aunque parece que el riesgo es pequeño, una nueva revisión sugiere que, en casos raros, la viruela del simio podría desencadenar unas complicaciones neurológicas graves, entre ellas convulsiones e in…
Learn MoreIn Rare Cases, Monkeypox Can Trigger Dangerous Brain Inflammation
MONDAY, Sept. 12, 2022 (HealthDay News) — Though the risk appears small, a new review suggests that, in rare instances, monkeypox may trigger serious neurological complications, including seizures and brain inflammation.The finding is based on a look…
Learn MoreResearch Reveals Cause of ‘Freezing’ Gait in Parkinson’s
MONDAY, Sept. 12, 2022 (HealthDay News) — Researchers think they’ve figured out why Parkinson’s disease causes a person’s limbs to become so stiff that at times they can feel frozen in place.Using a robotic chair equipped with sensors, a research tea…
Learn MoreUn panel de la FDA respalda a un controversial fármaco para la ELA en su segunda revisión, un paso raro
JUEVES, 8 de septiembre de 2022 (HealthDay News) — El miércoles, un panel de la Administración de Alimentos y Medicamentos (FDA) de EE. UU. recomendó la aprobación de un medicamento experimental para la ELA (esclerosis lateral amiotrófica) en una seg…
Learn MoreUna prueba sanguínea se muestra promisoria para un diagnóstico rápido de la ELA
MIÉRCOLES, 7 de septiembre de 2022 (HealthDay News) — Los pacientes con sospecha de esclerosis lateral amiotrófica (ELA) quizá puedan pronto recibir un diagnóstico con mucha más rapidez, y no desperdiciar el valioso tiempo que les queda, sugiere una …
Learn MoreIn Rare Move, FDA Panel Gives Support to Controversial ALS Drug in 2nd Review
THURSDAY, Sept. 8, 2022 (HealthDay News) – In a rare second review, a U.S. Food and Drug Administration panel on Wednesday recommended approval for an experimental drug for ALS (amyotrophic lateral sclerosis). The FDA is not obligated to follow its ad…
Learn MoreUn panel de la FDA se muestra escéptico sobre un controversial fármaco para la ELA antes de una votación
MARTES, 6 de septiembre de 2022 (HealthDay News) — Un panel de la Administración de Alimentos y Medicamentos (FDA) de EE. UU. sopesará de nuevo la aprobación de un medicamento experimental para la ELA, una segunda revisión poco común, para una enferm…
Learn More